|
The Immunohistochemistry Antibody Company
|
- Home
-
Products
- All Antibodies
- IHC-plus Antibodies
-
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
- Distributors
-
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
-
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us
|
|
Lung Cancer Screen 13 Tissue Microarray - LS-SLUCA13
This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.
|
|
| Catalog ID: |
LS-SLUCA13 |
| Product Name: |
Lung Cancer Screen 13 |
| Description: |
64 various lung cancer specimens (predominantly adenocarcinoma and squamous cell carcinoma) with stage/grade and clinical data |
| Format: |
FFPE |
| Category: |
Human Tumor |
| QA/QC: |
H&E reviewed |
| Storage: |
Short term RT; Long term 4ºC |
| Clinical History: |
Yes |
| Tissue Marker: |
No |
| Stage/Grade: |
Yes |
| Core Diameter: |
1.5 mm |
| Core Thickness: |
5-6 µm |
| Cases: |
66 |
| Cores: |
65 |
| Slides Per Set: |
1 |
LS-SLUCA13 Tissue Microarray Map
Slide Number 1
| LABEL | | | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | | A | Pla | | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | | B | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | | C | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | | D | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | | E | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | | F | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng | Lng |
|
Diagnosis Type Legend| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue LegendLung (Lng); Placenta (Pla);
LS-SLUCA13 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | TNM Tumor Classification | Tumor Differentiation | Tumor History | Tumor Size |
|---|
| 1 | A1 | Human | F | 29 y | Placenta (Pla) | Normal | Benign non-neoplastic | | | | |
| 1 | A3 | Human | M | 89 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N2M0 | Poorly-Moderately | 1 Month | 3x3x2.5 cm |
| 1 | A4 | Human | F | 28 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M1 | Moderately | 4 Months | 3x3x2.5 cm |
| 1 | A5 | Human | F | 45 y | Lung (Lng) | Bronchioloalveolar carcinoma | Malignant | T2N0M0 | Well | 3 Months | 4x3x2 cm |
| 1 | A6 | Human | M | 53 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N0M0 | Moderately | 1 Year | 6x5x1 cm |
| 1 | A7 | Human | F | 47 y | Lung (Lng) | Adenocarcinoma | Malignant | T3N3M1 | Poorly | 1 Month | 5x4x3.5 cm |
| 1 | A8 | Human | M | 65 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N3M1 | Poorly | 20 Days | 3.3x3x2.5 cm |
| 1 | A9 | Human | M | 58 y | Lung (Lng) | Adenocarcinoma | Malignant | T3N0M0 | Moderately-Well | 1 Month | 5x4x3 cm |
| 1 | A10 | Human | M | 64 y | Lung (Lng) | Bronchioloalveolar carcinoma | Malignant | T2N2M0 | Moderately | 2 Months | 2x2x1 cm |
| 1 | A11 | Human | M | 54 y | Lung (Lng) | Bronchioloalveolar carcinoma | Malignant | T2N0M0 | Moderately | 1 Month | 4x3x3 cm |
| 1 | B1 | Human | M | 58 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | Moderately | 6 Months | 2x2x2 cm |
| 1 | B2 | Human | F | 60 y | Lung (Lng) | Bronchioloalveolar carcinoma | Malignant | T3N0M0 | Moderately | 3 Months | 6x5x5 cm |
| 1 | B3 | Human | M | 58 y | Lung (Lng) | Metastatic mucoepithelioid cancer | Metastatic | T2N0M0 | Moderately | 1 Month | 4x3x3 cm |
| 1 | B4 | Human | M | 55 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N3M1 | Moderately-Well | 20 Days | 5x4x4 cm |
| 1 | B5 | Human | M | 50 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N2M1 | Poorly | 1 Month | 7x5x4.5 cm |
| 1 | B6 | Human | M | 43 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | Well | 6 Months | 3x3 cm |
| 1 | B7 | Human | F | 60 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N3M1 | Moderately | 17 Months | 2.5x2x2 cm |
| 1 | B8 | Human | F | 56 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | Poorly | 15 Days | 3.5x3x3 cm |
| 1 | B9 | Human | M | 60 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3 N0M0; T3N0M0 | Moderately | 1 Month | 6x5x4 cm |
| 1 | B10 | Human | M | 53 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N3M1 | Poorly | 14 Months | 15x15x7 cm |
| 1 | B11 | Human | F | 53 y | Lung (Lng) | Squamous cell carcinoma | Malignant | TxN0M0 | Moderately | 1 Month | |
| 1 | C1 | Human | M | 54 y | Lung (Lng) | Adenosquamous carcinoma | Malignant | T2N2M1 | Moderately | 2 Months | 2.5x2x1 cm |
| 1 | C2 | Human | M | 60 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3 N0M0; T3N0M0 | Poorly | 1 Month | 5x4.5x4 cm |
| 1 | C3 | Human | F | 54 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N3M0 | Moderately | 50 Days | 4x4x4 cm |
| 1 | C4 | Human | F | 50 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N2M0 | Poorly-Moderately | 1 Month | 4x3.5x3.5 cm |
| 1 | C5 | Human | M | 57 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3 N3M1; T3N3M1 | Poorly | 40 Days | 5x5x4 cm |
| 1 | C6 | Human | F | 57 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | Poorly | 3 Months | 4x3.5x3.5 cm |
| 1 | C7 | Human | F | 62 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | Moderately | 45 Days | 4x3x3 cm |
| 1 | C8 | Human | F | 58 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | Moderately | 1 Month | 4x3x3 cm |
| 1 | C9 | Human | M | 65 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N3M0 | Poorly-Moderately | 40 Days | 5x5x4 cm |
| 1 | C10 | Human | M | 56 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N2M0 | Poorly-Moderately | 21 Days | 3x2.8x2.5 cm |
| 1 | C11 | Human | M | 30 y | Lung (Lng) | Adenocarcinoma | Malignant | T3N2M1 | Poorly | 3 Days | 5x4.5x2 cm |
| 1 | D1 | Human | F | 50 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | Moderately | 1 Month | 4x4x3 cm |
| 1 | D2 | Human | F | 35 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | Moderately | 3 Months | 2.5x2x2 cm |
| 1 | D3 | Human | M | 40 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N2M0 | Moderately | 15 Days | 3.9x3.5x2.5 cm |
| 1 | D4 | Human | F | 52 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | Moderately | 1 Month | 4x3.5x3.5 cm |
| 1 | D5 | Human | M | 39 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N1M0 | Poorly-Moderately | 29 Days | 4x3.8x3.5 cm |
| 1 | D6 | Human | M | 53 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | Moderately | 12 Days | 3.8x3.5x3.2 cm |
| 1 | D7 | Human | M | 49 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N3M0 | Moderately | 5 Months | 3.4x2.9x2.5 cm |
| 1 | D8 | Human | F | 63 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N0M0 | Moderately | 1 Month | 5x4x4 cm |
| 1 | D9 | Human | M | 57 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | Moderately | 20 Days | 1.5x1x1 cm |
| 1 | D10 | Human | F | 39 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N2M0 | Poorly-Moderately | 40 Days | 4.5x4x4 cm |
| 1 | D11 | Human | M | 70 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N2M0 | Moderately | 15 Days | 4.3x4x3.8 cm |
| 1 | E1 | Human | M | 69 y | Lung (Lng) | Adenocarcinoma | Malignant | T3N0M0 | Poorly | 1 Month | 5x4x4 cm |
| 1 | E2 | Human | M | 63 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | Poorly | 5 Months | 3x2x1.5 cm |
| 1 | E3 | Human | F | 60 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | Poorly-Moderately | 20 Days | 3.2x2.7x2 cm |
| 1 | E4 | Human | M | 58 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N2M0 | Moderately | 3 Months | 5x4x4 cm |
| 1 | E5 | Human | F | 47 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | Poorly | 1 Month | 2x2x1.5 cm |
| 1 | E6 | Human | M | 49 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N2M0 | Poorly-Moderately | 2 Months | 10x10x8.7 cm |
| 1 | E7 | Human | M | 54 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | Poorly-Moderately | 1 Month | 4x3x3 cm |
| 1 | E8 | Human | M | 63 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N3M0 | | 40 Days | 3x3x2 cm |
| 1 | E9 | Human | F | 60 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N2M0 | Poorly | 24 Days | 4x3.5x3.2 cm |
| 1 | E10 | Human | M | 58 y | Lung (Lng) | Adenocarcinoma | Malignant | T3N0M0 | Moderately | 40 Days | 5x4.5x4 cm |
| 1 | E11 | Human | M | 46 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N2M0 | Moderately | 1.5 Months | 6x5x5 cm |
| 1 | F1 | Human | M | 60 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N3M0 | Moderately | 42 Days | 3.7x3x3 cm |
| 1 | F2 | Human | M | 57 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N2M0 | Poorly | 4 Months | 3.7x3x3 cm |
| 1 | F3 | Human | M | 62 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N1M0 | Poorly-Moderately | 60 Days | 5x4x4 cm |
| 1 | F4 | Human | M | 55 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N3M0 | Poorly-Moderately | 40 Days | 5x5x4 cm |
| 1 | F5 | Human | M | 72 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N2M1 | Poorly | 45 Days | 1.5x4.8x4 cm |
| 1 | F6 | Human | M | 63 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N2M0 | Moderately | 1 Month | 3x2x2 cm |
| 1 | F7 | Human | M | 67 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | Poorly | 2 Months | Diameter 3 cm |
| 1 | F8 | Human | M | 66 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N3M0 | Poorly | 3 Months | Diameter 8 cm |
| 1 | F9 | Human | M | 66 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N2M0 | Moderately | 1 Year | Diameter 2.5 cm |
| 1 | F10 | Human | F | 67 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | Moderately | 3 Months | Diameter 4.8 cm |
| 1 | F11 | Human | F | 62 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N1M0 | Poorly | 20 Days | 3x2.5x2.2 cm |
Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved
